Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06008457
What this trial is testing

Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

Who this might be right for
COVID-19 Respiratory InfectionInfluenza AInfluenza Type B+1 more
Sequenom, Inc. 1,600
Testing effectiveness (Phase 2)Looking for participantsNCT07482657
What this trial is testing

Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus

Who this might be right for
RSV InfectionRSVRespiratory Syncytial Virus (RSV)
Enanta Pharmaceuticals, Inc 150
Early research (Phase 1)Study completedNCT02668367
What this trial is testing

Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

Who this might be right for
PharmacokineticsHealthy Volunteers
Biota Pharmaceuticals, Inc. 36
Not applicableUnknownNCT05765838
What this trial is testing

Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.

Who this might be right for
InfluenzaCOVID-19RSV Infection
Rigshospitalet, Denmark 250
Not applicableActive Not RecruitingNCT05929599
What this trial is testing

Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections

Who this might be right for
Acute Respiratory Tract InfectionsPneumoniaRespiratory Syncytial Virus (RSV)
National Children's Hospital, Vietnam 120
Large-scale testing (Phase 3)Study completedNCT06389487
What this trial is testing

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,459
Early research (Phase 1)Study completedNCT04927793
What this trial is testing

Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects

Who this might be right for
Respiratory Syncytial Virus (RSV)
Enanta Pharmaceuticals, Inc 8
Testing effectiveness (Phase 2)Looking for participantsNCT07628049
What this trial is testing

Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections+Metapneumovirus
GlaxoSmithKline 1,456
Not applicableLooking for participantsNCT06172660
What this trial is testing

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

Who this might be right for
RSV Infection
Yale University 3,750
Not applicableActive Not RecruitingNCT07249320
What this trial is testing

Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants

Who this might be right for
Respiratory Syncytial Virus (RSV)
Pfizer 1
Not applicableStudy completedNCT00609635
What this trial is testing

Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly

Who this might be right for
Respiratory Syncytial Virus Infections
West Penn Allegheny Health System 300
Large-scale testing (Phase 3)Ended earlyNCT06397768
What this trial is testing

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunization
Sanofi Pasteur, a Sanofi Company 2,226
Post-approval studies (Phase 4)Looking for participantsNCT05045612
What this trial is testing

Antibiotic Therapy in Viral Airway Infections

Who this might be right for
Infectious DiseaseInfluenzaRespiratory Syncytial Virus (RSV)+1 more
University Hospital, Akershus 380
Early research (Phase 1)Study completedNCT04519073
What this trial is testing

Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus

Who this might be right for
Acute Bronchiolitis Due to Respiratory Syncytial Virus
Virometix 60
Early research (Phase 1)Study completedNCT03674177
What this trial is testing

Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 502
Large-scale testing (Phase 3)Study completedNCT05169905
What this trial is testing

Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 9
Not applicableStudy completedNCT04748445
What this trial is testing

Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.

Who this might be right for
Healthy
Pfizer 9,151
Not applicableStudy completedNCT01140048
What this trial is testing

Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)

Who this might be right for
Respiratory Syncytial Virus Bronchiolitis
Organon and Co 343
Early research (Phase 1)UnknownNCT06313697
What this trial is testing

Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2102 in Healthy Adult

Who this might be right for
Respiratory Syncytial Virus Infections
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 132
Early research (Phase 1)Study completedNCT03782662
What this trial is testing

Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 82
Next Page